AT313912B - Verfahren zur Herstellung von Azetidinonen-(2) - Google Patents

Verfahren zur Herstellung von Azetidinonen-(2)

Info

Publication number
AT313912B
AT313912B AT821771A AT821771A AT313912B AT 313912 B AT313912 B AT 313912B AT 821771 A AT821771 A AT 821771A AT 821771 A AT821771 A AT 821771A AT 313912 B AT313912 B AT 313912B
Authority
AT
Austria
Prior art keywords
azetidinones
preparation
Prior art date
Application number
AT821771A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AT313912B publication Critical patent/AT313912B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT821771A 1970-09-23 1971-09-22 Verfahren zur Herstellung von Azetidinonen-(2) AT313912B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702046822 DE2046822A1 (de) 1970-09-23 1970-09-23 Neue Azetidinone-(2) und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
AT313912B true AT313912B (de) 1974-03-11

Family

ID=5783147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT821771A AT313912B (de) 1970-09-23 1971-09-22 Verfahren zur Herstellung von Azetidinonen-(2)

Country Status (5)

Country Link
AT (1) AT313912B (de)
BE (1) BE772990A (de)
DE (1) DE2046822A1 (de)
FR (1) FR2108456A5 (de)
NL (1) NL7112824A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162250A (en) * 1976-09-08 1979-07-24 Smithkline Corporation 3-Aminoazetidinone derivatives
JPS56125360A (en) * 1980-03-07 1981-10-01 Sagami Chem Res Center Beta-lactam compound
US5229510A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. β-lactams useful in determining the amount of elastase in a clinical sample
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4680391A (en) * 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5348953A (en) * 1991-06-25 1994-09-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
EP0666846A1 (de) * 1992-10-27 1995-08-16 Merck & Co. Inc. Neue substituierte azetiddione als entzündungshemmende und antidegenerative mittel
US5591737A (en) * 1992-12-17 1997-01-07 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
DE2046822A1 (de) 1972-03-30
BE772990A (fr) 1972-03-23
NL7112824A (de) 1972-03-27
FR2108456A5 (en) 1972-05-19

Similar Documents

Publication Publication Date Title
AT299195B (de) Verfahren zur Herstellung von N-(1,1,1,-trisubstituierten)-Methylazolen
AT308105B (de) Verfahren zur Herstellung von Dibenzylaminofluoranverbindungen
AT320144B (de) Verfahren zur Herstellung von 7-Amino-3-methyl-3-cephem-4-carbonsäuren
AT313912B (de) Verfahren zur Herstellung von Azetidinonen-(2)
AT313471B (de) Verfahren zur Herstellung von 7-Halogen-7-deoxy-lincomycinen
AT310714B (de) Verfahren zur Herstellung von 4-Oxocapronitril
CH532584A (de) Verfahren zur Herstellung substituierter N-Cycloalkylarylamino-imidazoline-(2)
AT305230B (de) Verfahren zur Herstellung von 2-Äthylhexanal-(1)
AT306922B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
AT322732B (de) Verfahren zur herstellung von 7-aminocephalosporansäuren
AT308980B (de) Verfahren zur Herstellung von 21-Desoxy-21-N-(N'-methylpiperazinyl)-prednisolon
AT310960B (de) Verfahren zur Herstellung von 6α-Methyl-19-nor-pregnenen
AT306235B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
AT289052B (de) Verfahren zur Herstellung von 3-Ketobutanol-(1)
CH497428A (de) Verfahren zur Herstellung von 1-Formyl-3-nitro-azacyclo-heptanon-(2)
CH540906A (de) Verfahren zur Herstellung von 7'-Formylzearalan
AT306032B (de) Verfahren zur Herstellung von 4-Hydroxy-6-halogenmethyl-pyrimidinen
AT315143B (de) Verfahren zur Herstellung von Cyclopropylmethylalkylaminen
AT308724B (de) Verfahren zur Herstellung von 1-(4'-Hydroxyphenyl-3'-hydroxymethylphenyl)-2-aminoäthanolen
AT314542B (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen
AT309393B (de) Verfahren zur Herstellung von reinem 2,2-Dimethylpropandiol-(1,3)
AT303277B (de) Verfahren zur herstellung von neuem 9 alpha-fluor-16-fluormethylenprednisolon-21-oenanthat
AT304483B (de) Verfahren zur Herstellung von Alkylphthalsäuren
AT312577B (de) Verfahren zur Herstellung von Bicyclo-[3,3,0]-octen-(2)
AT310770B (de) Verfahren zur Herstellung von Oxaziridinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee